展開選單
About Us
Our Company
Team
Milestone & Recognitions
Partners and Collaborations
Research
Antroquinonol
Pipeline
Clinical Trials
Supporting Publications
About Alzheimer's Disease
News & Events
Press Releases
Events
Business Development
Contact Us
搜尋
繁中
EN
收合選單
搜尋
EN
繁體中文
English
HOME
News
Breakthrough in AML Treatment_GoldenBiotech Reports Phas 2 Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed AML
News
Nov 12, 2020
Breakthrough in AML Treatment_GoldenBiotech Reports Phas 2 Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed AML
BACK TO LIST